Jul 10, 2020, 08:53 by User Not Found

Clinical Research News | It could take up to two years to develop robust controlled human infection models for SARS-CoV-2 that meet essential criteria for limiting risk for study volunteers, according to a recent report in the New England Journal of Medicine. This, plus more, is included in this week’s announcements and updates from the clinical research industry.

Jul 9, 2020, 17:16 by

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced the launch of its new business intelligence platform, BEYOND. Designed to encompass more than just early risk detection, this extended visualization solution takes CluePoints beyond the interrogation of data and allows Sponsor and CRO users to explore areas of interest in one integrated business intelligence system.

Jul 9, 2020, 17:16 by

snapIoT announces a new feature for it's snapClinical platform - IRB Packaging and UAT Reporting. This feature was designed to automate and expedite the submission process of patient engagement solutions for IRB and ethics approvals which allows Pharmas and CROs to quickly deploy decentralized trials in a faster and more reliable manner.

Jul 9, 2020, 17:15 by

Intermediates for API about Flu Treatment Are Now Available at Alfa Chemistry

Jul 9, 2020, 17:15 by

AI & Medicine Releases Biomarker Discovery and Targeted Proteomics Services for Researchers

Jul 9, 2020, 17:15 by

Creative Biolabs has combined with integrated, multidisciplinary drug discovery expertise and unparalleled scope of capabilities in SARS-CoV-2 candidates screening, effective viral inhibitors discovery, therapeutic antibody development and vaccine exploration.

Jul 9, 2020, 17:15 by

Jul 9, 2020, 17:15 by

Jul 9, 2020, 17:15 by

Jul 9, 2020, 17:15 by

A customer since 2015, Boehringer Ingelheim has renewed its partnership with TrialScope for an additional five years.

Jul 9, 2020, 17:15 by

TrialScope, the global leader in clinical trial transparency, has hired Chris Venezia as Chief Commercial Officer, expanding its executive team.

Jul 8, 2020, 10:00 by User Not Found

Clinical Research News | Patient influencers have been a growing trend in the patient advocacy space, serving as mediators between clinical researchers and the patients they hope to treat.

Jul 7, 2020, 08:14 by User Not Found

Clinical Research News | While adherence in clinical research may seem straightforward, analysis conducted by AiCure shows that the issue of adherence—or more accurately non-adherence—can take many forms.

Jul 2, 2020, 07:46 by User Not Found

Clinical Research News | New data shed light on the potential variations in T-cell responses as a function of disease severity, an issue that is key to understanding the potential role of immunopathology in COVID-19, and also inform vaccine design and evaluation. Meanwhile, universities are continuing to build out their telehealth capabilities in light of the pandemic. This, plus more, are included in this week’s announcements and updates from the clinical research industry.

Jun 29, 2020, 08:26 by User Not Found

Clinical Research News | Therapeutic plasma exchange, a 30-year-old clinical procedure, could explode in popularity if its mouse equivalent holds true in humans—reduction in damaging proteins that have been implicated in diseases such as Alzheimer’s disease and heart failure.

Jun 26, 2020, 08:54 by User Not Found

Clinical Research News | New research indicates that COVID-19 disproportionately affects those of lower socioeconomic status and greater household crowding. Meanwhile, companies are forming a crowd-sourcing initiative to jump start COVID-19 data collection. This, plus more, are included in this week’s announcements and updates from the clinical research industry.

Jun 25, 2020, 15:56 by

Jun 25, 2020, 15:56 by

Jun 25, 2020, 15:56 by

Jun 25, 2020, 15:56 by